Arrowhead Pharmaceuticals Corp (ARWR)

13.39 +0.41 (3.16%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (12/11/18 *Est.)

Latest Headlines

Baker Bros. Advisors 13F for Quarter Ended Sept. 30, 2018 November 14, 2018 4:55 PM - StreetInsider Form 4 ARROWHEAD PHARMACEUTICAL For: Nov 09 Filed by: Anzalone Christopher Richard November 9, 2018 7:02 PM - SEC Filing Arrowhead Pharma (ARWR) Presents Late-Breaking Preliminary Clinical Data on ARO-HBV at Liver Meeting November 9, 2018 12:00 PM - StreetInsider Arrowhead Pharmaceuticals Presents Late-Breaking Preliminary Clinical Data on ARO-HBV at Liver MeetingĀ® 2018 November 9, 2018 12:00 PM - BizWire Arrowhead Pharmaceuticals Presents Late-Breaking Clinical Data on ARO-AAT at Liver MeetingĀ® 2018 November 9, 2018 12:00 PM - BizWire Arrowhead Pharmaceuticals to Present at Upcoming November 2018 Conferences November 1, 2018 7:30 AM - BizWire Arrowhead Pharmaceuticals Announces Closing of Agreements with Janssen October 31, 2018 7:30 AM - BizWire Form 4 ARROWHEAD PHARMACEUTICAL For: Oct 22 Filed by: GIVEN DOUGLAS B October 23, 2018 8:08 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: Oct 19 Filed by: Leone Peter Brian October 23, 2018 8:01 PM - SEC Filing Arrowhead Pharmaceuticals Hosts R&D Day on Pipeline of RNAi Therapeutics October 16, 2018 12:01 PM - BizWire Arrowhead Pharmaceuticals Corp (ARWR) Reports Filing for Regulatory Clearance to Begin Phase 1 Study of ARO-ANG3 October 15, 2018 7:31 AM - StreetInsider Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-ANG3 October 15, 2018 7:30 AM - BizWire Arrowhead Pharmaceuticals Corp (ARWR) to Present Late-Breaking Clinical Data on ARO-AAT and ARO-HBV at AASLD October 11, 2018 12:08 PM - StreetInsider Arrowhead to Present Late-Breaking Clinical Data on ARO-AAT and ARO-HBV at AASLD Liver MeetingĀ® 2018 October 11, 2018 12:05 PM - BizWire Arrowhead Research (ARWR) PT Raised to $24 at Cantor Fitzgerald October 4, 2018 10:27 AM - StreetInsider Arrowhead Research (ARWR) PT Raised to $25 at Piper Jaffray October 4, 2018 10:26 AM - StreetInsider Pre-Open Movers 10/04: (BKS) (CLDR) (HDP) Higher; (RTEC) (WLDN) (SNAP) Lower (more...) October 4, 2018 9:30 AM - StreetInsider Form 8-K ARROWHEAD PHARMACEUTICAL For: Oct 04 October 4, 2018 9:17 AM - SEC Filing J&J, Arrowhead in gene-silencing drug deal worth up to $3.7 billion October 4, 2018 7:52 AM - StreetInsider Arrowhead Pharmaceuticals Corp (ARWR) Climbs 25% After Shares Resume Trading October 4, 2018 7:51 AM - StreetInsider Arrowhead Pharmaceuticals Corp (ARWR) to Resume Trading at 7:50 am ET October 4, 2018 7:33 AM - StreetInsider Arrowhead (ARWR) Announces $3.7 Billion License and Collaboration Agreements with Janssen (JNJ) October 4, 2018 7:32 AM - StreetInsider Arrowhead Enters $3.7 Billion License and Collaboration Agreements with Janssen October 4, 2018 7:30 AM - BizWire Arrowhead Pharmaceuticals Corp (ARWR) Halted, News Pending October 4, 2018 7:25 AM - StreetInsider Arrowhead Pharmaceuticals to Present at Upcoming October 2018 Conferences September 25, 2018 7:30 AM - BizWire Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 24, 2018 7:30 AM - BizWire Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 21, 2018 4:00 PM - BizWire Form 4 ARROWHEAD PHARMACEUTICAL For: Sep 06 Filed by: Myszkowski Kenneth Allen September 10, 2018 6:33 PM - SEC Filing Arrowhead Research (ARWR) PT Raised to $24.50 at Chardan Capital Markets September 6, 2018 3:23 PM - StreetInsider Arrowhead Pharmaceuticals Corp (ARWR) Adds to Gains; Up 57% September 6, 2018 10:44 AM - StreetInsider Arrowhead Pharmaceuticals Corp's (ARWR) ARO-HBV Data Up Is 'Encouraging' Says Piper September 6, 2018 10:23 AM - StreetInsider Pre-Open Movers 09/06: (ARWR) (NVEV) (GPS) Higher; (GWRE) (DOCU) (PRQR) Lower (more...) September 6, 2018 9:28 AM - StreetInsider Arrowhead Pharmaceuticals Corp (ARWR) to Present Positive ARO-HBV Clinical Data Demonstrating HBsAg Reductions September 6, 2018 9:17 AM - StreetInsider B.Riley/FBR Upgrades Arrowhead Research (ARWR) to Buy September 6, 2018 8:26 AM - StreetInsider Arrowhead Presents New ARO-HBV Clinical Data Demonstrating HBsAg Reductions at World Gastroenterologists Summit September 6, 2018 7:30 AM - BizWire Form 4 ARROWHEAD PHARMACEUTICAL For: Aug 31 Filed by: Anzalone Christopher Richard September 5, 2018 4:24 PM - SEC Filing Arrowhead Pharmaceuticals Corp (ARWR) Reports Complete Dosing in Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease August 31, 2018 7:31 AM - StreetInsider Arrowhead Completes Dosing in Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease August 31, 2018 7:30 AM - BizWire Arrowhead Pharmaceuticals to Present at Upcoming September 2018 Conferences August 30, 2018 4:00 PM - BizWire Full Article List